January 11, 2016
A federal judge ruled Friday that Apotex's planned generic version of Daiichi Sankyo's blood pressure drug Benicar does not infringe a patent that Daiichi previously disclaimed, a decision that could reduce the generic exclusivity period held by Apotex's rival generics maker Mylan.
April 10, 2013
Mylan Pharmaceuticals Inc. Tuesday blasted Apotex Inc.'s attempt to strip it of its exclusive rights to market a generic version of Daiichi Sankyo Co. Ltd.'s hypertension drug Benicar, urging an Illinois federal judge to toss the case because Apotex's quest is impossible.
November 20, 2012
Apotex Inc. slapped Daiichi Sankyo Co. Ltd. with a patent suit in Illinois on Tuesday, seeking a noninfringement ruling which Apotex said could strip Mylan Laboratories Ltd. of exclusive rights to market a generic version of the hypertension drug Benicar.